Margaret A. Turk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Interests
Margaret A. Turk has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Suzanne McDermott
Editors-in-Chief
4 shared publications Margaret K. Formica
Departments of Public Health & Preventive Medicine and Urology, SUNY Upstate Medical University, Syracuse, NY, 13210, USA
2 shared publications- Scott D. Landes
Syracuse University, Syracuse, NY, USA
2 shared publications - Suzanne McDermott
City University of New York, Graduate School of Public Health and Health Policy (CUNY SPH), New York, NY, United States; The Environmental Justice to EnRich and enGage nYc [ENERGY] Center, City University of New York, Graduate School of Public Health and Health Policy (CUNY SPH), New York, NY, United States
2 shared publications - Brad Edward Dicianno
University of Pittsburgh
1 shared publication Bruce M. Gans
Department of Physical Medicine and Rehabilitation, Rutgers New Jersey Medical School, Newark, NJ, USA
1 shared publication
Latest Publications
- 22 May 2025
- Published by Elsevier in Disability and Health Journal
- Vol. 18 (3) , 101887
Federal policy at a crossroads—Safeguarding the rights and well-being of people with disabilities
- 22 May 2025
- Published by Elsevier in Disability and Health Journal
- Vol. 18 (3) , 101887
Federal policy at a crossroads—Safeguarding the rights and well-being of people with disabilities
- 22 May 2025
- Published by Elsevier in Disability and Health Journal
- Vol. 18 (3) , 101885
A founding Editor's reflections
- 22 May 2025
- Published by Elsevier in Disability and Health Journal
- Vol. 18 (3) , 101885
A founding Editor's reflections
- 9 April 2024
- Published by Elsevier in Disability and Health Journal
- Vol. 17 (3) , 101623
Covid-19 patterns among adults with intellectual and developmental disability and the general population in New York state during the first year of the pandemic
- 9 April 2024
- Published by Elsevier in Disability and Health Journal
- Vol. 17 (3) , 101623
Covid-19 patterns among adults with intellectual and developmental disability and the general population in New York state during the first year of the pandemic
- Open Access
- 19 September 2023
- Published by SAGE Publications in Journal of Pediatric Rehabilitation Medicine
- Vol. 16 (3) , 449-455
A call for action: Increasing the pediatric rehabilitation medicine workforce
Pediatric Rehabilitation Medicine (PRM) is a unique blend of traditional medical rehabilitation knowledge and skills primarily focused on temporary and/or permanent disability conditions of childhood onset throughout the age continuum, with an emphasis on promoting function and participation. Although there are two established pathways to enhance knowledge and skills in PRM, one a combined residency with Pediatrics and the other a PRM fellowship, there has been a relative decline in participants in this training, as has been seen across other subspecialties in Physical Medicine and Rehabilitation (PM&R) and other medical specialties. Based on pediatric rehabilitation physician surveys and the increasing prevalence of children with disabilities, there has been a call to consider opening PRM fellowships to physicians not trained in PM&R. This commentary proposes establishing a commission to lead a transparent and inclusive process to assure that all options to address issues related to optimizing PRM care are considered and provide a course of action to address the needs of children and adults with childhood onset disabilities.
- 19 September 2023
- Published by SAGE Publications in Journal of Pediatric Rehabilitation Medicine
- Vol. 16 (3) , 449-455
Open AccessA call for action: Increasing the pediatric rehabilitation medicine workforce
Pediatric Rehabilitation Medicine (PRM) is a unique blend of traditional medical rehabilitation knowledge and skills primarily focused on temporary and/or permanent disability conditions of childhood onset throughout the age continuum, with an emphasis on promoting function and participation. Although there are two established pathways to enhance knowledge and skills in PRM, one a combined residency with Pediatrics and the other a PRM fellowship, there has been a relative decline in participants in this training, as has been seen across other subspecialties in Physical Medicine and Rehabilitation (PM&R) and other medical specialties. Based on pediatric rehabilitation physician surveys and the increasing prevalence of children with disabilities, there has been a call to consider opening PRM fellowships to physicians not trained in PM&R. This commentary proposes establishing a commission to lead a transparent and inclusive process to assure that all options to address issues related to optimizing PRM care are considered and provide a course of action to address the needs of children and adults with childhood onset disabilities.
- 30 November 2020
- Published by Springer Nature in Applied Health Economics and Health Policy
- Vol. 19 (3) , 415-428
Prescription Drug Monitoring Programs and Opioid Prescriptions for Disability Conditions
Background There are variants of prescription drug monitoring programs (PDMPs) and different groups of patients who are prescribed opioids. Patients with disabilities and those with chronic conditions might have different experiences in physician prescribing practices for opioids, when compared to a comparison group without these conditions. Objective To determine differences in opioid prescriptions related to PDMPs for people without cancer-related pain and with disability conditions compared to other adult opioid users without cancer, using a national database. Method Opioid users were identified from the US Medical Expenditure Panel Survey. Disability groups were defined by diagnosis codes related to longstanding physical disability and inflammatory conditions. Our analyses used an event study framework and a difference-in-differences approach. Results During a two-year panel period, PDMPs did not reduce opioid prescriptions for individuals with disabilities who use opioids. Our data show that individuals with disabilities who use opioids, on average, have a higher incidence of continuous opioid use and significantly greater amounts prescribed compared to other adults who have opioid prescriptions. Conclusion PDMPs do not appear to affect prescribers’ initial or ongoing use of opioids for individuals with longstanding physical disabilities and those with inflammatory conditions. Thus, these adults have greater exposure to opioids, compared to other adults who were prescribed opioids.
- 30 November 2020
- Published by Springer Nature in Applied Health Economics and Health Policy
- Vol. 19 (3) , 415-428
Prescription Drug Monitoring Programs and Opioid Prescriptions for Disability Conditions
Background There are variants of prescription drug monitoring programs (PDMPs) and different groups of patients who are prescribed opioids. Patients with disabilities and those with chronic conditions might have different experiences in physician prescribing practices for opioids, when compared to a comparison group without these conditions. Objective To determine differences in opioid prescriptions related to PDMPs for people without cancer-related pain and with disability conditions compared to other adult opioid users without cancer, using a national database. Method Opioid users were identified from the US Medical Expenditure Panel Survey. Disability groups were defined by diagnosis codes related to longstanding physical disability and inflammatory conditions. Our analyses used an event study framework and a difference-in-differences approach. Results During a two-year panel period, PDMPs did not reduce opioid prescriptions for individuals with disabilities who use opioids. Our data show that individuals with disabilities who use opioids, on average, have a higher incidence of continuous opioid use and significantly greater amounts prescribed compared to other adults who have opioid prescriptions. Conclusion PDMPs do not appear to affect prescribers’ initial or ongoing use of opioids for individuals with longstanding physical disabilities and those with inflammatory conditions. Thus, these adults have greater exposure to opioids, compared to other adults who were prescribed opioids.
- Top Cited Papers
- 1 July 2020
- Published by Elsevier in Disability and Health Journal
- Vol. 13 (3) , 100942
Intellectual and developmental disability and COVID-19 case-fatality trends: TriNetX analysis
- 1 July 2020
- Published by Elsevier in Disability and Health Journal
- Vol. 13 (3) , 100942
Top Cited PapersIntellectual and developmental disability and COVID-19 case-fatality trends: TriNetX analysis
- Open Access
- 1 April 2020
- Published by Elsevier in Disability and Health Journal
- Vol. 13 (2) , 100833
Survey of U.S. adults with spina bifida
- 1 April 2020
- Published by Elsevier in Disability and Health Journal
- Vol. 13 (2) , 100833
Open AccessSurvey of U.S. adults with spina bifida
- 19 July 2019
- Published by Springer Nature
- p. 289-313
“Please Look Beyond My Disability”
- 12 May 2018
- Published by Elsevier in Disability and Health Journal
- Vol. 11 (3) , 331-332
Disability, stress, and health disparities
- 12 May 2018
- Published by Elsevier in Disability and Health Journal
- Vol. 11 (3) , 331-332
Disability, stress, and health disparities